The Scientist

» clinical trials

Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: The Year in Pathogens

The Year in Pathogens

By | December 29, 2014

Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research

0 Comments

image: Ebola Update

Ebola Update

By | December 17, 2014

Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics

0 Comments

image: Ebola Update

Ebola Update

By | December 11, 2014

NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more

1 Comment

image: New NIH IRB Guidelines Proposed

New NIH IRB Guidelines Proposed

By | December 8, 2014

A draft policy from the US National Institutes of Health suggests that clinical studies performed at multiple sites should be reviewed by a single institutional review board.

0 Comments

image: Ebola Vaccine Candidate Shows Promise

Ebola Vaccine Candidate Shows Promise

By | December 1, 2014

An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.

0 Comments

image: Cannabis Biotech

Cannabis Biotech

By | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.

2 Comments

image: Push For Data Disclosure

Push For Data Disclosure

By | November 21, 2014

Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.

0 Comments

image: Ebola Drug Trials to Start in Africa

Ebola Drug Trials to Start in Africa

By | November 13, 2014

Researchers will test antiviral drugs and transfusions of blood from Ebola survivors in the West African countries hardest hit by the epidemic.

0 Comments

image: LabCorp Buys CRO

LabCorp Buys CRO

By | November 4, 2014

The $6 billion deal marks yet another massive transaction in the health-care industry.

1 Comment

Popular Now

  1. Scientists Activate Predatory Instinct in Mice
  2. Superbug Resistant to Every Antibiotic in the U.S. Killed Nevada Woman
  3. Next Generation: Mobile Microscope Detects DNA Sequences
  4. Tenure Under Attack in Two More States
    The Nutshell Tenure Under Attack in Two More States

    Proposed legislation would eliminate academic tenure at public universities in Iowa and Missouri, echoing a move that has already gutted such permanent posts in Wisconsin.

RayBiotech